UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

The Activation of Natural Killer Cell Effector Functions by Cetuximab-Coated, Epidermal Growth Factor Receptor–Positive Tumor Cells is Enhanced By Cytokines

Clinical cancer research, 2007-11, Vol.13 (21), p.6419-6428

2007

Volltextzugriff (PDF)

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

Molecular cancer therapeutics, 2009-11, Vol.8 (11), p.2983-2991

2009

Volltextzugriff (PDF)

CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells

The Journal of immunology (1950), 2005-08, Vol.175 (3), p.1619-1627

2005

Volltextzugriff (PDF)

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes

Blood, 2011-01, Vol.117 (1), p.323-332

2011

Volltextzugriff (PDF)

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model

The Journal of immunology (1950), 2012-09, Vol.189 (6), p.3168-3177

2012

Volltextzugriff (PDF)

Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis

The Journal of immunology (1950), 2011-08, Vol.187 (4), p.1970-1976

2011

Volltextzugriff (PDF)

Correction: Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer

The Journal of immunology (1950), 2020-12, Vol.205 (11), p.3231-3231

2020

Volltextzugriff (PDF)

The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells

Cancer immunology research, 2021-11, Vol.9 (11), p.1283-1297

2021

Volltextzugriff (PDF)

CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody

Blood, 2010-02, Vol.115 (6), p.1204-1213

2010

Volltextzugriff (PDF)

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

The Journal of immunology (1950), 2011-03, Vol.186 (6), p.3401-3409

2011

Volltextzugriff (PDF)

Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer

The Journal of immunology (1950), 2020-10, Vol.205 (8), p.2301-2311

2020

Volltextzugriff (PDF)

ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms

Cancer immunology research, 2024-05, Vol.12 (5), p.592

2024

Volltextzugriff (PDF)

Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets

Journal of Immunology, 2006-07, Vol.177 (1), p.120-129

2006

Volltextzugriff (PDF)

Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.517-526

2006

Volltextzugriff (PDF)

Hypoxia Inducible Factors-Mediated Inhibition of Cancer by GM-CSF: A Mathematical Model

Bulletin of mathematical biology, 2012-11, Vol.74 (11), p.2752-2777

2012

Volltextzugriff (PDF)

Fcγ Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies

The Journal of biological chemistry, 2013-09, Vol.288 (37), p.26800-26809

2013

Volltextzugriff (PDF)

Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (19), p.9099-9107

2005

Volltextzugriff (PDF)

Preclinical Characterization of NGM936, a Novel Bispecific T Cell Engager Targeting ILT3 for the Treatment of Acute Myeloid Leukemia with Monocytic Differentiation

Blood, 2022-11, Vol.140 (Supplement 1), p.9063-9064

2022

Volltextzugriff (PDF)

A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.671-672

2022

Volltextzugriff (PDF)

Abstract LB156: Preclinical evaluation of NGM707, a novel anti-ILT2/anti-ILT4 dual antagonist monoclonal antibody

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB156-LB156

2021

Volltextzugriff (PDF)

Colocalization of the IL-12 receptor and FcγRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-γ

Blood, 2008-04, Vol.111 (8), p.4173-4183

2008

Volltextzugriff (PDF)

Abstract LB216: Pre-clinical characterization of NGM831, an ILT3 antagonist antibody for the treatment of solid tumors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB216-LB216

2022

Volltextzugriff (PDF)

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model1

The Journal of immunology (1950), 2012-08, Vol.189 (6), p.3168-3177

2012

Volltextzugriff (PDF)

FcγRIIIa role in rituximab efficacy

Blood, 2007-10, Vol.110 (7), p.2220-2220

2007

Volltextzugriff (PDF)

HIF-2α regulates GM-CSF-derived sVEGFR-1 production from macrophages and inhibits tumor growth and angiogenesis1

The Journal of immunology (1950), 2011-07, Vol.187 (4), p.1970-1976

2011

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(41)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Humans
(17)
Animals
(16)
Mice
(16)
Cell Line, Tumor
(11)
Female
(10)
Immunology
(10)
Biological And Medical Sciences
(9)
Killer Cells, Natural - Immunology
(9)
Medical Sciences
(8)
Oncology
(8)
Antibodies, Monoclonal, Humanized
(7)
Interferon-Gamma - Biosynthesis
(6)
Killer Cells, Natural - Metabolism
(6)
Macrophages - Metabolism
(5)
Mice, Inbred Balb C
(5)
Trastuzumab
(5)
Antibodies, Monoclonal - Administration & Dosage
(4)
Cytokines - Metabolism
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Activation of Natural Killer Cell Effector Functions by Cetuximab-Coated, Epidermal Growth Factor Receptor–Positive Tumor Cells is Enhanced By Cytokines

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model

Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis

Correction: Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer

The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells

CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer

ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms

Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets

Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells

Hypoxia Inducible Factors-Mediated Inhibition of Cancer by GM-CSF: A Mathematical Model

Fcγ Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies

Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12

Preclinical Characterization of NGM936, a Novel Bispecific T Cell Engager Targeting ILT3 for the Treatment of Acute Myeloid Leukemia with Monocytic Differentiation

A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma

Abstract LB156: Preclinical evaluation of NGM707, a novel anti-ILT2/anti-ILT4 dual antagonist monoclonal antibody

Colocalization of the IL-12 receptor and FcγRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-γ

Abstract LB216: Pre-clinical characterization of NGM831, an ILT3 antagonist antibody for the treatment of solid tumors

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model1

FcγRIIIa role in rituximab efficacy

HIF-2α regulates GM-CSF-derived sVEGFR-1 production from macrophages and inhibits tumor growth and angiogenesis1

Suchergebnisse filtern